Mendez, Edem M.
HRN: 22-84-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2023
CEFTRIAXONE 1G (VIAL)
04/11/2023
04/18/2023
IV
1g
Q12h
For Orif
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes